BioTuesdays

Author - Sydney Stewart

Itamar Medical
Markets

Piper Sandler starts Itamar Medical at OW; PT $22

Piper Sandler launched coverage of Itamar Medical (NASDAQ:ITMR) with an “overweight” rating and $22 price target. The stock closed at $16 on Feb. 4. Itamar makes home sleep testing products that are used to diagnose...

February 5, 2020
Accuray
Markets

BTIG ups Accuray to buy; PT $9.50

BTIG upgraded Accuray (NASDAQ:ARAY) to “buy” from “neutral,” with a price target of $9.50. The stock closed at $3.28 on Jan. 17. Last week, Accuray announced a compound annual growth rate revenue outlook of 8% to 12%...

January 21, 2020
iRhythm Technologies
Markets

WB starts iRhythm Technologies at OP

William Blair launched coverage of iRhythm Technologies (NASDAQ:IRTC) with an “outperform” rating, calling the company’s digital health platform “market disrupting.” The stock closed at $71.76, up $1.12, on Jan. 9...

January 10, 2020
Valeritas Holdings Logo
Markets

BTIG cuts Valeritas Holdings to neutral; removes PT

BTIG downgraded Valeritas Holdings (NASDAQ:VLRX) to “neutral” from “buy” and removed its previous $10 price target after the company reduced its fourth quarter revenue guidance due to a temporary supply disruption and...

December 23, 2019
X4 Pharma
Markets

Roth starts X4 Pharma at buy; PT $20

Roth Capital Partners launched coverage of X4 Pharmaceuticals (NASDAQ:XFOR) with a “buy” rating and $20 price target. The stock closed at $11 on Dec. 17. Analyst Zegbeh Jallah writes that her investment thesis is based...

December 18, 2019